10x Genomics (TXG)
(Delayed Data from NSDQ)
$25.99 USD
-0.40 (-1.52%)
Updated May 10, 2024 04:00 PM ET
After-Market: $26.03 +0.04 (0.15%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Price, Consensus and EPS Surprise
TXG 25.99 -0.40(-1.52%)
Will TXG be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for TXG based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TXG
International Markets and 10x Genomics (TXG): A Deep Dive for Investors
10x Genomics (TXG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
TXG: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp
3 Medical Products Stocks Set to Beat This Earnings Season
Down -23.92% in 4 Weeks, Here's Why 10x Genomics (TXG) Looks Ripe for a Turnaround
Other News for TXG
Shhh! 3 Secret Nanotech Stocks Flying Below Wall Street’s Radar
Scotiabank Keeps Their Hold Rating on Torex Gold Resources (TORXF)
Torex Gold Sets Stage for Strong 2024
10x Genomics stock slides amid German patent court ruling
Bruker says German court rules against 10x Genomics patent claim